Exam 5 (final) - Ott depression Flashcards
DSM-5 diagnostic criteria says at least one of the symptoms needed to see to diagnose with depression is __________ or ___________
depressed mood, loss of interest or pleasure in doing things
(in diagnostic criteria) SIGE stands for:
sleep (too much or too little)
interest decreased
guilt/worthlessness
energy loss/fatigue
(in diagnostic criteria) CAPS stands for:
concentration difficulties
appetite change (increase or decrease)
psychomotor agitation
suicidal ideation
PHQ-9 is for
primary care setting
-used repeatedly to determine efficacy of treatment
5=minimal
10=mild
15=moderately-severe
20=severe
MDQ is for
used to rule out BPD
-5 questions
positive score of BPD is when >7 yes responses occur
boxed warning for ALL antidepressants aged 24 or younger
suicidality
-especially relevant in first 1-2months of therapy and after any dose changes
citalopram clinical pearls (SSRI)
QTc prolongation
2C19 and 3A4 substrate
fluoxetine clinical pearls (SSRI)
long t1/2 (96-144 hrs)
2D6 inhibitor, 3A4 inhibitor
fluvoxamine clinical pearls (SSRI)
inhibitor of 1A2 and 2C19
paroxetine clinical pearls (SSRI)
must taper due to anticholinergic effects
-weight gain, sedation
birth defect to septal wall of fetus
inhibitor of 2D6 and 2B6
sertraline clinical pearls (SSRI)
GI upset (more than other antidepressants)
SSRI SE
weight gain (most with paroxetine)
weight loss (most with fluoxetine)
sexual dysfxn
hyponatremia
increased bleed risk (platelet inhibition)
desvenlafaxine clinical pearls (SNRI)
active metabolite of venlafaxine
nausea is big issue
no major CYP interactions
14:1, 5HT:NE
duloxetine clinical pearls (SNRI)
titrate up to avoid nausea
warning for hepatotoxicity (monitor LFTs)
inhibitor of 2D6
10:1
levomilnacipran clinical pearls (SNRI)
adjust dose for:
-renal impairment
-strong 3A4 inhibitors
3A4 substrate
1:2
venlafaxine clinical pearls (SNRI)
must be >150mg/day to get NE effects
2D6 inhibitor at high doses
30:1
SNRI SE
increased BP
nausea